Literature DB >> 2529832

Association between gold induced skin rash and remission in patients with rheumatoid arthritis.

D Caspi1, M Tishler, M Yaron.   

Abstract

The coincidence of skin eruption and remission induced by gold has not previously been reported. In 50 out of 247 patients with rheumatoid arthritis treated with gold salts (Solganal) between 1977 and 1987 treatment was stopped owing to adverse reactions. Skin rashes were present in 31 patients, 10 had nephropathy, and nine patients had aphthous stomatitis. All 31 patients who developed skin eruption entered a concomitant clinical and laboratory remission. The remission satisfied the American Rheumatism Association preliminary criteria and was accompanied by a significant decrease of mean erythrocyte sedimentation rate from 43 (SD 13) to 25 (11) mm/h. Disease was exacerbated in 23 patients after three to 60 months. Eight patients are in remission at present, five to 68 months after gold treatment was discontinued. In contrast, no remission was noticed among the 19 patients with nephropathy or stomatitis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529832      PMCID: PMC1003864          DOI: 10.1136/ard.48.9.730

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.

Authors:  M Tishler; D Caspi; E Gazit; M Yaron
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

2.  Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens.

Authors:  G Ferraccioli; F Peri; A Nervetti; U Ambanelli; M Savi
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

3.  Forty-seven years experience with gold therapy in 1,019 rheumatoid arthritis patients.

Authors:  L M Lockie; D M Smith
Journal:  Semin Arthritis Rheum       Date:  1985-05       Impact factor: 5.532

4.  Gold salts in the treatment of rheumatoid arthritis. A double-blind study.

Authors:  J W Sigler; G B Bluhm; H Duncan; J T Sharp; D C Ensign; W R McCrum
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

5.  HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.

Authors:  O Scherak; J S Smolen; W R Mayr; F Mayrhofer; G Kolarz; N J Thumb
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

6.  Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.

Authors:  W F Kean; T P Anastassiades
Journal:  Arthritis Rheum       Date:  1979-05

7.  HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P Perrier; C Raffoux; P Thomas; J N Tamisier; M Busson; A Gaucher; F Streiff
Journal:  Ann Rheum Dis       Date:  1985-09       Impact factor: 19.103

8.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

9.  Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors:  R S Pinals; A T Masi; R A Larsen
Journal:  Arthritis Rheum       Date:  1981-10
  9 in total
  7 in total

1.  Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area.

Authors:  J Hamilton; I B McInnes; E A Thomson; D Porter; J A Hunter; R Madhok; H A Capell
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

2.  Prospective six year follow up of patients withdrawn from a randomised study comparing parenteral gold salt and methotrexate.

Authors:  O Sander; G Herborn; E Bock; R Rau
Journal:  Ann Rheum Dis       Date:  1999-05       Impact factor: 19.103

3.  Insights into the mechanism of gold action provided by immunotoxicology: biooxidation of gold(I) to gold(III) detected by sensitized T-cells.

Authors:  E Gleichmann; M Kubicka-Muranyi; P Kind; R Goldermann; G Goerz; H Merk; R Rau
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

4.  Association between gold induced skin rash and remission in patients with rheumatoid arthritis.

Authors:  P Fremont-Smith; K Fremont-Smith
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

Review 5.  Have traditional DMARDs had their day? Effectiveness of parenteral gold compared to biologic agents.

Authors:  Rolf Rau
Journal:  Clin Rheumatol       Date:  2004-07-24       Impact factor: 2.980

6.  Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.

Authors:  S M Wilkinson; A G Smith; M J Davis; D Mattey; P T Dawes
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

7.  Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.

Authors:  A Svensson; J Theander
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.